About us
Expertise
International
People
Careers
News & publications
Contact us
Home
»
News & publications
»
Latest news
News & publications
Related news & insights - James Went
Penningtons Manches Cooper appointed as legal advisor to Advanced Research + Invention Agency (ARIA)
Posted: 28/11/2023
Penningtons Manches Cooper’s Birmingham and Oxford offices have been appointed as legal advisors to the Advanced Research + Invention Agency (ARIA), a new R&D agency built to unlock scientific and technological breakthroughs to benefit everyone.......>>
Penningtons Manches Cooper advises Imperial University spin-out SPARTA Biodiscovery on fundraise and industry partnership
Posted: 01/11/2023
The corporate team at Penningtons Manches Cooper has advised Imperial University spin-out, SPARTA Biodiscovery, on its partnership and up to £3.5 million funding from international life sciences group, Sartorius. SPARTA Biodiscovery was created to bring novel analytical methods to the development and production of nanoparticles......>>
Penningtons Manches Cooper advises advanced satellite technology company Open Cosmos on $50 million fundraise
Posted: 20/10/2023
The corporate team at Penningtons Manches Cooper has advised Open Cosmos on securing its $50 million Series B funding round led by Trill Impact, A&G and ETF Partners. Open Cosmos designs, builds and operates satellites, offering end-to-end space mission services, and uses the power of satellites to simplify and democratise access......>>
Penningtons Manches Cooper advises world-leading medical technology company OrganOx on £25 million fundraise
Posted: 04/08/2023
The corporate team at Penningtons Manches Cooper has advised OrganOx on a £25 million growth round led by Lauxera Capital Partners, with support from existing investors. OrganOx is a world-leading medical technology company committed to making every donated organ count with metra, a fully automated normothermic......>>
Penningtons Manches Cooper advises Torpedo Factory Group Limited on its acquisition by Aukett Swanke
Posted: 02/05/2023
The corporate team at Penningtons Manches Cooper has acted for Torpedo Factory Group Limited, a leading audio, visual and stage technology provider to organisations in the UK and Europe, on its acquisition by AIM listed Aukett Swanke. Torpedo Factory Group is a technology systems integrator and services business operating primarily......>>
Penningtons Manches Cooper advises tech start-up EcoSync on further fundraise
Posted: 03/02/2023
The corporate team at Penningtons Manches Cooper has advised tech start-up EcoSync on securing additional funding as it continues its expansion, focusing on reducing energy usage in the built environment. EcoSync offers room-by-room energy services for commercial buildings across the UK, with a mission to reduce energy waste......>>
Penningtons Manches Cooper advises Celleron Therapeutics on the completion of its merger with Argonaut Therapeutics to form IngenOx Therapeutics
Posted: 18/01/2023
The corporate team at Penningtons Manches Cooper has advised University of Oxford spinout Celleron Therapeutics, a clinical-stage biopharmaceutical company advancing a pipeline of precision medicine drugs for advanced cancer indications, on the completion of its merger with Argonaut Therapeutics to form IngenOx Therapeutics......>>
Penningtons Manches Cooper advises Simply Sustainable on its majority investment from Agathos Management LLP
Posted: 04/01/2023
The corporate team at Penningtons Manches Cooper has advised the shareholders of Simply Sustainable, a London-headquartered ESG and sustainability consultancy known for its deep sustainability expertise, on the majority investment from Agathos Management LLP, a lower mid-market private equity firm......>>
Penningtons Manches Cooper advises Seloxium on its spin-out from Oxford University
Posted: 07/11/2022
The corporate team at Penningtons Manches Cooper has advised Seloxium on the completion of its spin-out from Oxford University and initial seed funding led by Oxford Science Enterprises in cooperation with Oxford University Innovation, the University’s technology transfer office......>>
Penningtons Manches Cooper advises Seedrs on $100 million acquisition by Republic
Posted: 08/09/2022
The corporate team at Penningtons Manches Cooper has advised Seedrs, Europe’s leading online private investment platform, on its completed acquisition by Republic for $100 million. This is a landmark transaction which creates a business working globally to transform the world of private investment......>>
1
2
3
4
Filter news & insights
Filter by keyword:
Filter by expertise:
Select an area of expertise
Banking and finance
Cauda Equina Syndrome claims
Charities
Clinical negligence
Commercial
Company secretarial services
Construction and infrastructure
Corporate
Corporate tax
Cosmetic surgery claims
Court of Protection and deputyships
Cyber security and cyber crime
Cycle and bike accident claims
Data protection and privacy
Digital business
Education
Elderly care claims
Employee share schemes
Employment for Business
Employment for Individuals
Energy regulatory
Equity capital markets
Family law
Fashion and luxury brands
Financial services
Financial services regulation
Fintech
Funding a personal injury claim
Gender pay gap reporting
Holiday accident claims
Hospital fall claims
Housing governance
Immigration for Business
Inquest representation
Inquest representation
Intellectual property
International trade
IT and telecommunications
Life sciences
Marine, trade and energy
Ophthalmology claims
Pensions
Personal injury
Planning
Private client and tax
Product liability claims
Product liability claims
Real estate
Real estate investors
Real estate litigation
Regulatory compliance
Renewable energy and cleantech
Residential property and conveyancing
Retail
Shipping
Social housing
Social housing management
Sports and entertainment
Stillbirth and neonatal death claims
Surgical error claims
Technology
Technology transfer and spin-outs
Travel
Vaginal mesh claims
In this section
Latest news
Archive news
Publications
Media enquiries
Contact our press team on:
+44 (0)20 7457 3258
+44 (0)7887 888105 (out of hours)